← Back to Clinical Trials
Recruiting NCT04336579

NCT04336579 Diaphragmatic Breathing Exercises in Total Knee Arthroplasty Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04336579
Status Recruiting
Phase
Sponsor University of Southern California
Condition Anesthesia and Analgesia
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-06-10
Primary Completion 2024-10-01

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
Diaphragmatic Breathing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2024-06-10 with a primary completion date of 2024-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Rationale: While total knee replacements (TKA) are one of the most commonly performed surgical procedures in the United States, this procedure can also be very painful. Postoperative mobilization and rehabilitation is vital to a patient's recovery, but inadequate pain control can impede patients' progress. Diaphragmatic breathing is an additional non-pharmacological and non-invasive tool with no adverse effects that could aid in recovery. This will serve as a pilot study for a possible larger controlled trials.

Eligibility Criteria

Inclusion Criteria: * Patients (participants) undergoing total knee arthroplasty with a continuous peripheral nerve block catheter Exclusion Criteria: * Inability to perform or learn diaphragmatic breathing exercises or do not wish to participate in diaphragmatic breathing or study protocol * Pregnant patients * Patients without continuous peripheral nerve block catheter

Contact & Investigator

Central Contact

Linda J Rever, MD

✉ rever@usc.edu

📞 3234427400

Principal Investigator

Linda J Rever, MD

PRINCIPAL INVESTIGATOR

University of Southern California

Frequently Asked Questions

Who can join the NCT04336579 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 90 Years, studying Anesthesia and Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04336579 currently recruiting?

Yes, NCT04336579 is actively recruiting participants. Contact the research team at rever@usc.edu for enrollment information.

Where is the NCT04336579 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT04336579 clinical trial?

NCT04336579 is sponsored by University of Southern California. The principal investigator is Linda J Rever, MD at University of Southern California. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology